20-OH-LTB4

CAS : 79516-82-8

Ref. 3D-EDA51682

Informations sur le produit

• Nom: 20-OH-LTB4
• Synonymes: (5S,6Z,8E,10E,12R,14Z)-5,12,20-Trihydroxy-6,8,10,14-eicosatetraenoic acid, (5S,6Z,8E,10E,12R,14Z)-5,12,20-trihydroxyicosa-6,8,10,14-tetraenoic acid, 20-Hydroxy-LTB₄, 20-Hydroxyleukotriene B₄, 6,8,10,14-Eicosatetraenoic acid, 5,12,20-trihydroxy-, (5S,6Z,8E,10E,12R,14Z)-, 6,8,10,14-Eicosatetraenoic acid, 5,12,20-trihydroxy-, [S-[R*,S*-(E,Z,E,Z)]]-, ω-Hydroxy-LTB₄
• CAS: 79516-82-8

Description

20-OH-LTB4 is a medicinal compound with potential anticancer properties. It has been shown to induce apoptosis in human and Chinese hamster ovary cells, making it a promising candidate for cancer treatment. 20-OH-LTB4 also inhibits the cell cycle by targeting kinases and other proteins involved in cancer cell growth. This compound has been identified as a potent inhibitor of urine-derived protein kinase, which plays a key role in cancer progression. In addition to its potential as an anticancer agent, 20-OH-LTB4 may have broader applications as a general inhibitor of kinases and other enzymes involved in cellular signaling pathways.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 352.5 g/mol
• Formule: C₂₀H₃₂O₅
• Degré de pureté: Min. 95%